Depression is a pervasive and debilitating neuropsychiatric disorder. A single, low dose of the NMDA receptor (NMDAR) antagonist ketamine elicits a long-lasting antidepressant response in patients with treatment-resistant major depressive disorder. Developing mechanistic understanding of how NMDAR antagonism alters synapse and circuit function is pivotal to developing translatable, circuit-based therapies for depression. Here using viral vectors, anatomical tracing, fMRI, and optogenetic-assisted circuit analysis, we assessed the role of the NMDAR subunit GluN2B in regulating cellular, synaptic, and circuit-level function and depression-related behavior. We demonstrate that post-developmental deletion of GluN2B from pyramidal neurons in medial prefrontal cortex enhances action potential output in a synaptic activity-dependent manner. GluN2B deletion dictates functional connectivity between mPFC and limbic thalamus but not ventral hippocampus and elicits antidepressant-like behavior. Our findings demonstrate that postsynaptic GluN2B exerts inputspecific control of pyramidal neuron innervation, and identify a novel circuit for regulating depression-like behaviors in mice.
Introduction
One in twenty people experience a depressive episode in their lifetime 1 . The limited efficacy of primary treatments and limited accessibility of efficacious treatments leave a large proportion of depressed patients untreated 2 . N-methyl D-aspartate receptors (NMDARs) represent an important and mechanistically distinct class of targets for treatment of major depressive disorder (MDD) [3] [4] [5] [6] . A low dose of the NMDAR antagonist ketamine elicits antidepressant effects in treatment-resistant patients within 110 minutes, with this single dose remaining efficacious over placebo for at least 7 days 7 . While clinical work has broadened the scope of disorders targetable by NMDAR antagonism, pre-clinical studies are providing a mechanistic understanding of how it is that a brief period of NMDAR modulation has such powerful and sustained effects on mood. Recent work suggests that antagonism of GluN2B-containing NMDARs on forebrain pyramidal neurons is a sufficient and necessary component of ketamine's antidepressant-like actions [8] [9] [10] [11] . However, it is not clear which forebrain regions and brain circuits play a causal role in inducing the antidepressant-like effects of NMDAR antagonism.
The medial prefrontal cortex (mPFC) is involved in the motivational aspects of depression-related behavior in rodents and its activity is bi-directionally affected by the induction of depression or treatment with antidepressant drugs [12] [13] [14] . It has been demonstrated that a single treatment with low-dose ketamine or the GluN2B-subunit selective antagonist Ro 25-6981 results in an increase in excitatory input onto mPFC neurons in rodents coincident with the antidepressant-like response 9, 11, 14 . The distinct inputs giving rise to these strengthened synaptic connections and their role in altering mPFC circuit function, however, remains unknown.
In the current study, we demonstrate that post-developmental deletion of GluN2B from pyramidal neurons in mPFC is sufficient to elicit antidepressant-like behavior in mice. GluN2B deletion enhances excitatory synaptic drive onto layer 3 pyramidal neurons in mPFC, resulting in a synaptic activity-dependent facilitation of action potential output. Using optogenetic-assisted electrophysiology, we found that synaptic remodeling following GluN2B deletion occurs at local mPFC microcircuits engaged by inputs from the medial dorsal thalamus (MDT), but not the ventral hippocampus (vHipp). Finally, to observe alterations in activity of mPFC-connected nuclei in vivo, we employed arterial spin labeling (ASL)-based perfusion fMRI after mPFC GluN2B deletion and observed altered perfusion in mPFC and MDT. Together these data strongly implicate mPFC GluN2B-containing NMDARs in regulating depression-related behavior, and suggest that input-specific control over mPFC microcircuits may underlie such behavioral changes.
Results

Deletion of GluN2B from mPFC pyramidal neurons elicits antidepressant-like behavior
Selective, forebrain deletion of GluN2B from cortical pyramidal neurons is sufficient to recapitulate the antidepressant actions of ketamine. Application of ketamine results in no additional antidepressant effect in these mutant animals, suggesting that ketamine exerts its effects by antagonizing GluN2B-containing NMDARs in forebrain pyramidal neurons 9 . However, it is not clear which forebrain regions and circuits play a causal role inducing the antidepressant-like effects of ketamine.
The mPFC is a primary locus of top-down executive control over the processing of aversive and appetitive stimuli, and has a wellestablished role in the regulation of mood [15] [16] [17] [18] . For these reasons we sought to determine if removal of GluN2B from pyramidal neurons in mPFC alone would be sufficient to elicit antidepressantlike effects. To specifically remove GluN2B from mPFC excitatory neurons, we targeted an adeno-associated virus (AAV) expressing
Cre-GFP or a GFP control virus under the CaMKII promotor (AAV2-CaMKII-GFP-T2A-Cre or AAV2-CaMKII-GFP) bilaterally to the superficial layers of the prelimbic mPFC of GluN2B floxed adult mice (2BΔ mPFC mice, Figure 1A -C). Two weeks after injection, minimal colocalization of GFP and markers for parvalbumin and somatostatin was observed, demonstrating specificity of this intervention to principal neurons (Supplemental Figure 1) .
Furthermore, a reduction in GluN2B protein immunoreactivity was observed in cells infected with Cre-GFP, but not GFP alone, suggesting effective deletion of GluN2B (Supplemental Figure 1) .
Two weeks post-surgery, mice were assessed on two paradigms of depression-related behavior with good face validity and strong predictive validity for antidepressant efficacy [19] [20] [21] . Relative to GFP injected controls, Cre-injected mice lacking GluN2B in pyramidal neurons of mPFC (2BΔ mPFC mice) displayed decreased immobility times on both the forced swim test (FST) and tail suspension test (TST) ( Figure 1D ). To control for potential confounding alterations in locomotion, mice were assessed in the open field test (OFT).
Analysis revealed no alterations in locomotor activity in 2BΔ mPFC mice ( Figure 1E ). Therefore, deletion of GluN2B from mPFC cortical Figure 2C ). Synaptic recordings revealed a significant increase in the amplitude of EPSCs in 2B∆ mPFC neurons, while no change in IPSC amplitudes was observed ( Figure 2D ).
Alternatively, we observed no significant change in the frequency of either excitatory or inhibitory PSCs ( Figure 2E ). Integrating excitatory and inhibitory amplitudes and frequencies to calculate an overall synaptic drive ratio 22, 23 revealed a 110.6% increase in the relative excitation experienced by 2B∆ mPFC neurons ( Figure 2F ).
These data demonstrate that GluN2B deletion enhances excitatory synaptic drive onto to layer 3 pyramidal neurons and augments their firing probability and information transfer downstream.
Investigating intrinsic excitability of 2B∆ mPFC neurons
To test for alterations in intrinsic excitability of 2B∆ mPFC neurons, we injected hyperpolarizing or depolarizing current steps from70mV and recorded the resultant change in voltage. We observed no significant alteration in the current-voltage relationship (Supplemental Figure 2A ) nor in the input-output relationship between control and 2B∆ mPFC cells (Supplemental Figure 2B ).
Qualitative assessment of the hyperpolarizing current steps suggested that the HCN-mediated sag potential was enhanced in 2B∆ mPFC neurons, although the recording conditions were not suited 26, 27 , thalamus 28, 29 , dorsal root ganglion 30 and modeled in cortex 31 .
In fast synaptic isolation and with TTX and Ba 2+ to block voltage gated sodium channels and inwardly rectifying potassium channels, respectively, we applied hyperpolarizing voltage steps from -50mV
to -130mV to these neurons (Supplemental Figure Figure 2G ), demonstrated as a -7.98mV shift in the V1/2 of 2B∆ mPFC neurons (Supplemental Figure   2H ). Because the increase in 2B∆ mPFC cells' Ih is observable only at potentials hyperpolarized to that at which we measured action potential firing it is unlikely that alterations in this property contributes to the enhanced spontaneous firing phenotype observed in 2B∆ mPFC cells seen in Figure 2A ,B. However, due to potential incomplete space clamp when using potassium-based internal solution, a role for Ih in this effect cannot be ruled out. The involvement of HCN channels in MDD and animal models of depression has precedence in the literature [33] [34] [35] and requires further study.
Identification of mPFC input nuclei
The observation that GluN2B deletion results in enhanced excitatory synaptic drive onto layer 3 pyramidal neurons led us to ask, which cortically-projecting nuclei might be responsible for sending this enhanced excitation to mPFC? Unstructured, global enhancement of synaptic input from all upstream projections would increase noise and eliminate specificity of information flow into and out from mPFC, and would presumably be detrimental to cortical processing [36] [37] [38] . We hypothesized that modification of a specific behavior (in this case depression-related behaviors, in the absence of locomotive alterations) is instead likely due to altered connectivity with a subset of connected brain regions.
The medial dorsal thalamus (MDT) is an association nucleus and the primary thalamic input to mPFC. Unlike relay nuclei in the thalamus, MDT receives no direct sensory input from the periphery.
Instead, MDT integrates inputs from ventral pallidum (VP, GABAergic), substantia nigra (SN, GABAergic, dopaminergic), ventral tegmental area (VTA, dopaminergic), amygdala (Amg, glutamatergic) and dorsal raphe nucleus (DRN, undefined) and sends forward this "emotionally rich" information to mPFC [39] [40] [41] [42] [43] [44] [45] .
This circuit is essential for regulation of working memory and behavioral flexibility [46] [47] [48] and is defective in mouse models of and patients with neuropsychiatric disorders [49] [50] [51] . The ventral hippocampus (vHipp) is a spatially and functionally distinct section of the hippocampal formation 52 . It has established roles in the expression of social behavior 53 , anxiety [54] [55] [56] [57] , and depression-related behavior 58 . In order to verify that our mPFC coordinates do in fact receive inputs form MDT and vHipp, we injected canine adenovirus type 2 expressing Cre recombinase (CAV-Cre) 59, 60 into the mPFC of the Ai14 Cre-dependent reporter mouse line 61 to selectively label neurons that send axonal inputs into mPFC (Supplemental Figure   3A ). Histological analysis confirmed direct inputs to mPFC from several brain regions including MDT, vHipp, and contralateral mPFC transfer from these presynaptic nuclei due to their differential ability to elicit postsynaptic action potential firing in mPFC.
Deletion of GluN2B from mPFC pyramidal neurons uniquely enhances MDT  mPFC inputs
Next, we investigated how these inputs are altered in the 2B∆ mPFC mouse. To this end, we combined optogenetic-assisted stimulation of MDT or vHipp inputs with viral-mediated deletion of GluN2B from postsynaptic mPFC pyramidal neurons ( Figure 4A,D) . We observed that postsynaptic deletion of GluN2B resulted in enhancement of glutamatergic MDT inputs measured as an enhancement of the high probability of release, depressing signature ( Figure 4B ). In contrast, no change was observed in vHipp inputs ( Figure 4E ). We additionally observed that MDTelicited feed-forward inhibition decremented more slowly in the absence of postsynaptic GluN2B ( Figure 4C ). MDT driven EPSCs, while having no effect on the amplitude of vHipp-driven EPSC amplitude ( Figure 5A , B, E, F)
Finally, we tested how this enhanced MDT input onto GluN2B-null cells relates to action potential output from these neurons. In Visualization of all ROIs at a descriptive level (secondary endpoints: Figure 7B ) demonstrates the brain-wide changes in perfusion, presented without statistical analysis.
Discussion:
Depression is a complex neuropsychiatric disorder arising from disruption of normal cellular, synaptic, and circuit functions involving the mPFC [64] [65] [66] [67] . The NMDAR antagonist ketamine has been shown to normalize these disrupted physiological features, alter functional connectivity of mPFC, and elicit antidepressant effects in human patients and rodent models of depression 14, 68, 69 58 , we found no alteration in functional connectivity between vHipp and mPFC in our model. This could represent divergent mechanisms for GluN2B-specific manipulation vs. mechanisms involving pan NMDAR antagonism. Developing our understanding of the NMDAR contributions at these individual inputs will be necessary to better understand the mechanisms at play.
Mechanism of action
How GluN2B deletion specifically alters the post-synaptic response to MDT input is another outstanding question that must be addressed. Our previous work demonstrated that deletion of GluN2B-containing NMDARs enhances the functional expression of AMPA receptors in neuronal culture and in vivo 9, 63 . We hypothesized that MDT axons innervate dendritic spines that contain a disproportionally large proportion of GluN2B-containing NMDARs and therefore have suppressed AMPA receptor interneurons 75 , as well as Schaffer Collaterals, which preferentially innervate GluN2B-containing CA1 synapses 76 .
Diverse forms of information transfer to mPFC
Specific upstream nuclei convey distinct information to mPFC pyramidal neurons and differentially regulate behavioral state.
Subcellular mapping revealed that layer 2 pyramidal neurons primarily receive input from thalamus at large spines onto distal dendrites and receive few inputs peri-somatically. Conversely, inputs from basolateral amygdala primarily synapse onto relatively smaller spines on proximal dendrites in layer 3. These differences would therefore have distinct consequences for synaptic integration in the postsynaptic cell 77 . High probability of release, depressing synapses enable postsynaptic neurons to respond to input stimulus trains more quickly, whereas low probability of release synapses require integration of inputs over expanded timescales 78 . We found that vHippmPFC glutamatergic inputs are weakly facilitating, whereas MDTmPFC inputs are high probability of release and depressing. Furthermore, deletion of GluN2B from mPFC enhances the high probability of release characteristics of MDT inputs, and therefore enhances firingcoupling between MDT and mPFC. Altered MDT-mPFC connectivity has been observed in patients with treatment-resistant depression 51 . Thus, it is possible that the enhanced MDTmPFC coupling we observed after deletion of GluN2B could underlie its antidepressant-like effect, although we have not tested a causal relationship in this study. Disrupting MDTmPFC coupling also leads to deficits in cognitive function 47 , implying that this manipulation might be pro-cognitive, although this also remains to be tested. 81 . Additionally, depressed patients with low MDT-dmPFC resting state functional connectivity were associated with better outcomes from dmPFC transcranial magnetic stimulation (TMS), and successful antidepressant response to TMS was associated with increases in MDT-dmPFC connectivity 82 .
Evidence from in vivo imaging studies
In our mouse fMRI studies we observed that after unilateral deletion of GluN2B in mPFC pyramidal neurons, regional activity is strongly increased in ipsilateral mPFC (at the Cre virus injection site) and decreased in ipsilateral MDT. Because ASL-based perfusion fMRI cannot determine directionality of circuit effects, and because the temporal resolution does not allow for parsing of monosynaptic vs network effects, one can only speculate as to the directionality of the observed perfusion changes. Since mPFC reciprocally projects to MDT, one obvious possibility is that the increased action potential output we observe is monosynaptically affecting activity in MDT. While the sign of this proposed change does not match the results of our perfusion fMRI, directionality of fMRI signal and neuronal activity are sometimes opposing 83 .
Alternatively, since changes in perfusion are affected more dramatically by alterations in synaptic release than by action potential firing 84, 85 , we could be observing a polysynaptic decrease in inhibition onto MDT. One intriguing possibility is that the mPFC (glutamatergic)  nucleus accumbens (GABAergic)  ventral pallidum (VP, GABAergic)  MDT pathway is involved. The increased action potential output we observe from mPFC might therefore di-synaptically decrease the amount of inhibitory drive from VP  MDT (resulting in decreased perfusion), and therefore enhance MDTmPFC drive. Although our a priori set of ROIs did not include VP, the descriptive radar plot we derived suggests that VP perfusion might be enhanced. However, further study will be necessary to elucidate the networks involved in the observed antidepressant effect.
Conclusions
In order to develop translatable circuit-based therapies for depressed patients, we must obtain a better understanding of the properties of relevant circuits that are impaired and seek to understand the mechanisms by which theses impairments are normalized after antidepressant treatment. We observed that 
Viral Manipulations
For spatially and temporally defined deletion of GluN2B, homozygous GluN2B floxed mice were injected with AAV2- 
CaMKII(0.4)-GFP(or RFP)-T2A-iCre or AAV2-CaMKII(0.4)-GFP(or RFP
)
Stereotaxic Surgery
Sterile instruments and personal protective equipment were used throughout these procedures. Mice were anaesthetized with a cocktail of fentanyl (0.05mg/kg), medetomidine (0.5mg/kg), and midazolam (5mg/kg) subcutaneously and subsequently lidocaine (2%) and bupivacaine (0.5%) locally at incision site under the scalp.
Animals were maintained at 35 °C throughout the surgery and afterwards until they were ambulatory. To avoid drying of the eyes during surgery, an ocular lubricant was applied. Animals' scalps were shaved and scrubbed with betadine. After anesthetic plane was confirmed, the mouse was placed into ear-bars on a stereotaxic frame and a single rostro-caudal incision was made to expose the skull surface. Up to four small holes were made with a dental drill, and viruses or toxins were injected into sites defined by Paxinos and Watson and Allen Brain Atlas, and then confirmed empirically.
Total volume per injection site varied from 100 to 300nl, as specified in the results section. Viruses were infused through a pulled glass capillary mounted to an automated microsyringe infusion pump system (Nanoject III, Drummond Scientific to closer match the composition of CSF in intact brains 87, 88 , and a small constant current was applied to set a baseline membrane potential of -50mV 89, 90 . NBQX (10μM), APV (100μM), and picrotoxin (50μM) was included in recordings in Figure 2G to achieve ionotropic synaptic isolation.
Ih voltage clamp experiments were recorded in NBQX (10μM), APV (100μM), and picrotoxin (50μM) to block ionotropic synaptic activity, TTX and Ba 2+ to block voltage-gated sodium and inwardlyrectifying potassium channels, respectively. As cesium blocks HCN channels, potassium gluconate internal solution was used in these recordings. Ih magnitude was measured as the difference between the initial current (immediately after the capacitive transient) to the steady state current (at the end of the 2.5s voltage step).
Amplitudes were normalized to individual cell capacitance to calculate Ih current density at a given voltage. Fractional activation of tail currents were measured relative to the largest tail current and data were fitted to a Boltzman function to determine halfactivation potential:
To record excitatory synaptic currents, cells were held at the measured GABA reversal potential (-68.5mV), and inhibitory currents were measured at the glutamate reversal potential (+2.5mV), corrected for liquid junction potential.
Photostimulation of synaptic terminals
2-4 weeks after injection of 200nl AAV2/8-hSyn-Chronos-GFP into
MDT or vHipp, acute brain slices were acquired as detailed above.
For each experiment, the target site "hit" was visually confirmed 
Mouse Behavior Open Field Test
Open field test was conducted using Accuscan open field system.
Mice were introduced into the arena at a fixed corner of an acrylic (42 x 42 x 30.5 cm) field arena and allowed to explore the arena freely. The arena was cleaned in between subjects with 70% ethanol.
Forced Swim Test
Forced swim test was carried out as described 91, 92 . Briefly, mice were introduced to a cylinder 15cm in diameter, 20cm height and filled to 15cm with room temperature water (23-26˚C) and the mice were unable to use their tails to support themselves with the bottom of the cylinder. Two to four mice were tested simultaneously with a screen to separate the cylinders. Videos were recorded from a top-mounted camera for 6min. After testing, mice were rubbed dry and placed under an infrared lamp for ~20 min.
Immobility in the last 4min of the test session was scored blind to genotype and treatment. The cylinders were cleaned in between subjects with 70% ethanol.
Tail Suspension Test
TST was performed as previously described 92 . Briefly, mice were suspended from their tails using adhesive tape and video recorded with between-subject factors "virus type" (GFP or Cre-GFP) and "injection mode" (bilateral or unilateral). Within this model, the groups "GFP (bilateral)" (n = 10) and "GFP (unilateral)" (n = 4) were jointly contrasted with the group "Cre-GFP (unilateral)" (n = 5). As a primary readout, the false discovery rate (FDR) was controlled at 10 % across a subset of 6 (× 2) ROIs defined a priori based on prior biological knowledge. In a more exploratory way, the same contrast was reported for the remaining ROIs at a descriptive level. 
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